The rising awareness about menopausal symptoms and their consequences on the health of Indian women is driving the growth of the India menopause treatment market during the forecast period. Hormone therapy, Gabapentin, and Clonidine are major treatment options for menopause in India.
The India osteoporosis drugs market is projected to grow during the forecast period because of the high incidence of osteoporosis in India and due to the rising geriatric population. The market is segmented by drug class and by route of administration. Some of the key players in the market are Cadila pharmaceuticals and Dr. Reddy's Laboratories.
The India multiple myeloma market is projected to grow as a result of the increasing prevalence of hematological cancers in India. The market is segmented by disease type, treatment type, diagnosis, dosage form, route of administration, end users and by distribution channel.
This report presents a strategic analysis of the India Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Acne Drugs Market, offering unmatched value, accuracy and expert insights.
The India home healthcare market is expected to witness growth from $6.59 Bn in 2022 to $15.12 Bn in 2030 with a CAGR of 10.93% for the year 2022-2030. Advancing technologies and the rising prevalence of lifestyle diseases in India are major market drivers. Some of the key players in the market include Portea and Apollo Homecare.
India is one of the fastest-growing dental markets in the world. The India dental care market is projected to grow from $653 Mn in 2022 to $1,339 Mn in 2030 with a CAGR of 9.4% for the year 2022-2030. The market is segmented by product, treatment, and by end users.
The India telemedicine market is expected to witness growth from $1.1 Bn in 2022 to $5.1 Bn in 2030 with a CAGR of 21.2% for the forecasted year 2022-2030. Telemedicine services in India include tele-hospitals, mHealth, and tele-homes. Apollo Telehealth Services and Practo Technologies are some of the key players in the market.
The India physiotherapy market is projected to grow from $967 Mn in 2022 to $1,907 Mn in 2030 with a CAGR of 8.85% for the year 2022-2030. The market is segmented by treatment, application and by practice type. Some of the key players in the India physiotherapy market are BTL Industries and Djo Global India Healthcare.
India's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.02 Bn in 2022 to $0.24 Bn by 2030, registering a CAGR of 38% during the forecast period of 2022 - 2030. The market will be driven by the rising number of startups in AI diagnostic technology and government initiatives. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Qure AI.
The India cardiovascular market is projected to grow from $1.00 Bn in 2022 to $1.79 Bn in 2030 with a CAGR of 7.52% for the year 2022-2030. Increased incidence of cardiovascular diseases and improvements in diagnosis and treatment options in India are the major drivers for the growth of the market.
Rising inclination of Indian consumers towards dietary supplements is projected to augment the growth of India vitamins and minerals market from $494 Mn in 2022 to $1,017 Mn in 2030 with a CAGR of 9.45% for the year 2022-2030. The market is segmented by ingredients, dosage form, functionality, and by end user.
India gastrointestinal drugs market is projected to grow as digestive problems are more common in Indian households. Major gastrointestinal disorders in India include gastroenteritis, celiac disease, and Crohn's disease. The market is segmented by drug type and by route of administration.